Cargando…
Recombinant asialoerythropoetin protects HL-1 cardiomyocytes from injury via suppression of Mst1 activation
BACKGROUND: Recombinant human erythropoietin (rhuEPO) and asialoerythropoietin (asialo-rhuEPO) are cardioprotective. However, the protective effects of rhuEPO could not be translated into clinical practice because of its hematopoiesis-associated side effects while non-erythropoietic asialo-rhuEPO is...
Autores principales: | Kittur, Farooqahmed S., Lin, Yuan, Arthur, Elena, Hung, Chiu-Yueh, Li, P. Andy, Sane, David C., Xie, Jiahua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327940/ https://www.ncbi.nlm.nih.gov/pubmed/30671548 http://dx.doi.org/10.1016/j.bbrep.2019.01.004 |
Ejemplares similares
-
Plant-Produced Asialo-Erythropoietin Restores Pancreatic Beta-Cell Function by Suppressing Mammalian Sterile-20-like Kinase (MST1) and Caspase-3 Activation
por: Arthur, Elena, et al.
Publicado: (2017) -
Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment
por: Kittur, Farooqahmed S., et al.
Publicado: (2023) -
Cytoprotective Effect of Recombinant Human Erythropoietin Produced in Transgenic Tobacco Plants
por: Kittur, Farooqahmed S., et al.
Publicado: (2013) -
Rethinking the necessity of low glucose intervention for cerebral ischemia/reperfusion injury
por: Xie, Jiahua, et al.
Publicado: (2021) -
Quantitative Proteomics Reveals the Beneficial Effects of Low Glucose on Neuronal Cell Survival in an in vitro Ischemic Penumbral Model
por: Li, Hua, et al.
Publicado: (2020)